JQ1 is a potent inhibitor of bromodomain-containing protein 4 (BRD4), which abolishes IFN-γ-induced PD-L1 expression on the surface of tumor cells, thus overcoming the acquired immune suppression37. Here, IFNG is linked to neoplasm.